Alivus Life Sciences, formerly Glenmark Life Sciences Limited, delivered a strong financial performance in the second quarter ...

The certification elevates the site’s global regulatory status, opening doors to European and other highly regulated markets ...

In a significant shift in its business mix, the company's Ex-US markets generated Rs 6,963 million in revenue, registering a ...

The growth was driven by a resilient diabetes portfolio, robust export performance and tighter cost management ...

The strong quarterly performance was backed by improved gross margins, which increased to 63% from 59.9% in the year-ago ...

Sanofi Consumer Healthcare India Limited reported a 12% year-on-year increase in revenue to Rs 263.1 crore for the third ...

With India stepping up its ambitions to strengthen its position in the global pharmaceutical manufacturing landscape, CPHI ...

Piramal Pharma has raised its FY27 revenue growth outlook to 19-20% after delivering strong first-half growth, with ...

Syngene International reported a 13% sequential rise in revenue from operations to Rs 833 crore in the second quarter of FY27 ...

Senores Pharmaceuticals Limited has reported its highest-ever quarterly revenue and EBITDA for the second quarter of FY27, with revenue climbing 24.9% year-on-year to Rs 192.3 crore, against Rs 153.9 ...

Zeus Hygia Lifesciences is stepping up its focus on sports nutrition innovation with two microencapsulated ingredients, CreaStab and CXR Energy, designed to address key formulation challenges as the ...

Approval clears the way for manufacturing at Nandesari plant, with commercial supplies expected to begin in H2 FY27 ...